Back to search results

Tele-CPASS vs. In-person CPASS for Stroke Recovery

This study is comparing two types of therapy for improving arm and hand movement after a stroke: Tele-CPASS and In-person CPASS therapy. Both are rehabilitation programs that involve 20 hours of guided exercises to help you use your arm and hand better. Tele-CPASS is done at home using a telehealth platform, while In-person CPASS therapy is done face-to-face in a clinic. The goal is to see if the home-based therapy is just as effective as clinic-based therapy, especially since it can be hard to get to in-person appointments. You could join if you are at least 21 years old, had a stroke within the last 40 days, and have ongoing weakness (hemiparesis) in your arm. The study will measure how well your arm and hand function improves over 12 months.

Study design
This study plans to enroll 42 participants who will be randomly assigned to receive either Tele-CPASS or In-person CPASS therapy.
What's involved
Participants will receive 20 hours of upper extremity motor training and will be followed for 1 year.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after starting the study to assess their arm and hand function.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07661849

Efficacy of Tele-CPASS Compared to In-person CPASS Therapy for Upper Extremity Motor Recovery

Recruiting
NAAges 21+InterventionalTreatment
University of Texas, El Paso
~42 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:Tele-CPASSIn-person CPASS therapy

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Upper Extremity Motor Function (Action Research Arm Test [ARAT])
Measured over Baseline, 3 months, 6 months, and 12 months

Conditions

Stroke
Hemiparesis
Upper Extremity Impairments
Stroke Rehabilitation

Explore related trials

Stroke

NCT07661849

Where you'd take part

This study runs at 3 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Rehabilitation Sciences Complex, University of Texas at El Paso, 3333 N Mesa St, El Paso, TX 79902

    El Paso, Texasstudy coordinator listed

    Recruiting

  • Texas Tech University Health Sciences Center El Paso - Neurology Clinic

    El Paso, Texasstudy coordinator listed

    Recruiting

  • University Medical Center of El Paso - Rehabilitation Services

    El Paso, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Dr. Shashwati Geed, PT, PhD · PRINCIPAL_INVESTIGATOR · Department of Physical Therapy and Movement Sciences, University of Texas at El Paso

Who to contact

Dr. Shashwati Geed, PT, PhD
[email protected]
915-747-7289
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 21 years or older
Neuroimaging-confirmed stroke within 40 days prior to enrollment
Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item
Able to participate in all study-related activities, including 1-year follow-up
Short Blessed Memory Orientation and Concentration Scale score less than 8
Able to follow 2-step commands
Montreal Cognitive Assessment (MoCA) score greater than 25
No upper extremity injury or condition that limited upper extremity use prior to the stroke

Exclusion

Inability to provide informed consent
Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication
Clinically significant fluctuations in mental status within 72 hours prior to randomization
Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse
Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item
Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item
Not expected to survive 12 months because of other illnesses
Pregnancy
Severe aphasia
Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period

What this trial measures

  • Upper Extremity Motor Function (Action Research Arm Test [ARAT])Baseline, 3 months, 6 months, and 12 months

    The Action Research Arm Test (ARAT) is a standardized, performance-based measure of upper extremity motor function. It assesses grasp, grip, pinch, and gross movement using a series of functional tasks. Scores range from 0 to 57, with higher scores indicating better motor function.